Journal of Clinical Immunology and Immunopathology Research
Subscribe to JCIIR
Full Name*
Email Address*

Article Number - 590B1FF53470


Vol.6(1), pp. 1-8 , June 2015
DOI: 10.5897/JCIIR2014.0068
ISSN: 1996-0816



Full Length Research Paper

Blood tissue cytological status of prognosis and predictive markers in the natural history of solid cancer development



Koanga Martin L. M
  • Koanga Martin L. M
  • Faculty of Sciences, Laboratory of Biochemistry, University of Douala, Cameroon.
  • Google Scholar
Embolo Elisee E.
  • Embolo Elisee E.
  • Faculty of Sciences, Laboratory of Biochemistry, University of Douala, Cameroon. 2Faculty of Medicine and Pharmaceutical Science, University of Douala, Cameroon.
  • Google Scholar
Eboumbou Carole E
  • Eboumbou Carole E
  • Faculty of Medicine and Pharmaceutical Science, University of Douala, Cameroon
  • Google Scholar
Olemba Clémence
  • Olemba Clémence
  • Douala General Hospital, Hematology Laboratory, Cameroon.
  • Google Scholar
Eloumou E. Landry
  • Eloumou E. Landry
  • Faculty of Sciences, Laboratory of Biochemistry, University of Douala, Cameroon.
  • Google Scholar
Assam Assam J. P.*
  • Assam Assam J. P.*
  • Faculty of Sciences, Laboratory of Biochemistry, University of Douala, Cameroon.
  • Google Scholar
Mouelle Albert S.
  • Mouelle Albert S.
  • Faculty of Medicine and Pharmaceutical Science, University of Douala, Cameroon. Douala General Hospital, Unity of Medical Oncology, Cameroon.
  • Google Scholar







 Received: 26 February 2014  Accepted: 26 May 2015  Published: 30 June 2015

Copyright © 2015 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0


Cancer is the major burden of disease worldwide. Each year, tens of millions of people are diagnosed with cancer around the world, and more than half of the patients eventually die from it. In many countries, cancer ranks the second most common cause of death following cardiovascular diseases. With significant improvement in treatment and prevention of cardiovascular diseases, cancer has or will soon become the number one killer in many parts of the world. The aim of this study was to optimize the means to support and diagnose early people living with solid cancers through blood exploration using flow cytometry. The techniques used included; complete blood count (CBC), flow cytometry and microscopy slides (smear). The data obtained from the microscopic analysis of blood cells searching for alterations after smear colored blade by May Grünwald Giemsa (MGG), revealed changes in size (anisocytosis) and shape (poikilocytosis) of erythrocytes with total absence of neutrophils. The main blood pathologies associated with these types of cancer obtained after CBC were: hypoglobinemia (30.76%), blood-concentration (18.75%) which marked the character of hypochromic blood tissue (true anemia), monocytosis (12.82%) and erythrocytopenia (12.82%). The decrease in the number of granules of polymorphonuclear cells and changes in the shapes of nuclei (lobularity) were observed in most patients, using the flow cytometry technique. Thus, alterations of blood tissue in solid cancers were identified and an algorithm for their exploitation has been developed to contribute to the understanding of natural history of solid cancer.


Key words: Solid cancer, epidemiology, cytological markers, flow cytometry. 

Ankri A, Binet JL, Charlotte, Choquet S, Davi F, Dhedin N, Leblond V, Toutan MI, Beral MH, Nguyen-Quoc S, Renaud M, Sutton L, Vallat L, Vernant JP (2005). Polycopié d'hématologie DCM 3. 192(10–51). Available at: http://s1.e-monsite.com/2008/10/07/48509814polydcem3-i-2007-2008-pdf.pdf
 
Atul B, Victor A (2010). Hematologie. Sciences médicales série Claude Bernard p. 175.
 
Dauchy S, Curé H (2008). Epidémiologie des cancers : que nous disent les données socioculturelles? Springer Psychooncology 2:217-224.
Crossref
 
Degenne M, Binet C (2009). Observation sanguines : érythrocyte normal, structure, composition chimique, métabolisme érythrocytaire. Available at : http://fmc.med.univ-tours.fr/Pages/Hemato/DES/A8-Erythrocyte-2009.pdf
 
Gavrilovic M, Maginot MJ, Schwartz-Gravilovic C, Wallach J (1996). Manipulation d'Analyse Biochimique. p 460
 
Lin-Hung W, Kuo ML, Chi-An C, Chia-Hung C, Wen-Fang C, Ming-Cheng C, Su JL, Chang-Yao H (2001). The anti-apoptotic role of interleukin-6 in human cervical cancer is mediated by up-regulation of Mcl-1 through a PI 3-K/Akt pathway. Oncogene. 20(41):5799-809.
Crossref
 
Ma X, Yu H (2006). Global Burden of Cancer. Yale J. Biol. Med. 79(3-4):85-94.
Pubmed
 
Méric JB, Morère JF (2005). Anémie chez les patients atteints de cancer pulmonaire. Cancer Bull. 92(5):439-44.
 
Milano M (2005). Cancer, anémie et place de l'érythropoïétine. J. Pharm. Clin. 24(1):11-6.
 
Rigal OBE, Druesne L, Chassagne L (2006). Épidémiologie: cancer et sujet âgé. Pcychooncology 3:141-146
Crossref
 
Robby K, Kumar AN, Anuj S (2012). Breast cancer tumors markers. J. Solid Tumors 2(1).
 
Vignot S, Spano JP (2005). Anémies et cancers colorectaux. Cancer Bull. 92(5):432-8
 
Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Mu-oz N (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189(1):12-9.
Crossref

 


APA Koanga, M. L. M., Embolo, E. E., Eboumbou, C. E., Olemba, C., Eloumou, E. L., Assam, A. J. P.,* & Mouelle, A. S. (2015). Blood tissue cytological status of prognosis and predictive markers in the natural history of solid cancer development. Journal of Clinical Immunology and Immunopathology Research, 6(1), 1-8.
Chicago Koanga Martin L. M., Embolo Elis&ee E., Eboumbou Carole E., Olemba Cl&emence, Eloumou E. Landry, Assam Assam J. P. and Mouelle Albert S.,. "Blood tissue cytological status of prognosis and predictive markers in the natural history of solid cancer development." Journal of Clinical Immunology and Immunopathology Research 6, no. 1 (2015): 1-8.
MLA Koanga Martin L. M., et al. "Blood tissue cytological status of prognosis and predictive markers in the natural history of solid cancer development." Journal of Clinical Immunology and Immunopathology Research 6.1 (2015): 1-8.
   
DOI 10.5897/JCIIR2014.0068
URL http://academicjournals.org/journal/JCIIR/article-abstract/590B1FF53470

Subscription Form